Orasure Technologies Incorporated operates in the Surgical and medical instruments sector. OraSure Technologies, Inc. is engaged in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its oral fluid technologies, as well as other diagnostic products, including immunoassays and other in-vitro diagnostic tests that are used on other specimen types, and other medical devices used for the removal of benign skin lesions by cryosurgery or freezing. The Company's diagnostic products include tests, which are performed on a rapid basis at the point of care, and tests that are processed in a laboratory. These products are sold in the United States and internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. In August 2011, the Company acquired DNA Genotek Inc. In our complete report available for purchase the company is compared to: Vascular Solutions, Inc., Kensey Nash Corporation and Endologix, Inc..